These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1322 related articles for article (PubMed ID: 32816320)
1. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax. Milligan R; Daher A; Villanueva G; Bergman H; Graves PM Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320 [TBL] [Abstract][Full Text] [Related]
2. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Milligan R; Daher A; Graves PM Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189 [TBL] [Abstract][Full Text] [Related]
3. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Rodrigo C; Rajapakse S; Fernando D Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362 [TBL] [Abstract][Full Text] [Related]
18. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299 [TBL] [Abstract][Full Text] [Related]
19. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563 [TBL] [Abstract][Full Text] [Related]